Grifols (NASDAQ:GRFS) is one of the overlooked growth stocks to buy now. On March 17, Grifols unveiled proof-of-concept data ...

Cognitive impairment in Parkinson’s disease (PD) represents a growing area of interest within neuroscience and clinical research, given PD's evolution from ...

Misbehaving T cells light up long before Parkinson’s symptoms show, zeroing in on vulnerable brain proteins. Their early surge could double as an alarm bell and a target for stop-it-early treatments.

Parkinson’s disease has long been considered an inevitable result of aging or mere bad luck, but recent scientific revelations suggest otherwise. Emerging research indicates that environmental factors ...

Florida has launched a statewide Parkinson’s disease registry to improve care for nearly 80,000 residents, while celebrity runners in the 2026 London Marathon are raising funds and awareness for ...